Trial Complexity is the New Normal

Clinical trial complexity is now the norm: more endpoints, more procedures, narrower eligibility criteria, and more data sources, with Phase III protocols collecting approximately 5.9 million data points on average and volume rising around 11% annually since 2020.

Guide

NEW: The Ultimate Guide to Modern, Regulatory-Grade RBQM

Press Release

CluePoints Launches Three AI-Led Clinical Data Review Capabilities, Co-Innovated with a Top 10 Pharmaceutical Company

Intelligent Query Detection, Medical & Safety Review and Intelligent Medical Coding are now generally available, extending...

Press Release

CluePoints Appoints Martin Magazzolo as Chief Commercial Officer

Wayne, PA – July 27, 2026 – CluePoints, provider of leading statistical and AI-driven software solutions,...

Press Release

CluePoints and Tufts CSDD Publish Peer-Reviewed Evidence Quantifying the Financial Value of RBQM

New research demonstrates RBQM-enabled trials achieve up to 23x ROI and 19% shorter phase durations, providing...